GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (FRA:698) » Definitions » FCF Yield %

Achilles Therapeutics (FRA:698) FCF Yield % : -44.23 (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Achilles Therapeutics's Trailing 12-Month Free Cash Flow is €-16.74 Mil, and Market Cap is €37.39 Mil. Therefore, Achilles Therapeutics's FCF Yield % for today is -44.23%.

The historical rank and industry rank for Achilles Therapeutics's FCF Yield % or its related term are showing as below:

FRA:698' s FCF Yield % Range Over the Past 10 Years
Min: -224.01   Med: 0   Max: 0
Current: -44.23


FRA:698's FCF Yield % is ranked worse than
72.73% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs FRA:698: -44.23

Achilles Therapeutics's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.


Achilles Therapeutics FCF Yield % Historical Data

The historical data trend for Achilles Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achilles Therapeutics FCF Yield % Chart

Achilles Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - -30.01 -193.28 -147.46

Achilles Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -141.29 - -

Competitive Comparison of Achilles Therapeutics's FCF Yield %

For the Biotechnology subindustry, Achilles Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achilles Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achilles Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Achilles Therapeutics's FCF Yield % falls into.



Achilles Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Achilles Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-45.437 / 30.81225
=-147.46%

Achilles Therapeutics's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 35.746473
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Achilles Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Achilles Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Achilles Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Achilles Therapeutics Business Description

Traded in Other Exchanges
Address
245 Hammersmith Road, London, GBR, W6 8PW
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Achilles Therapeutics Headlines

No Headlines